Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Coya Therapeutics, Inc. (COYA) had Return on Tangible Equity of -49.33% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$7.95M |
|
$-21.23M |
|
-- |
|
$7.95M |
|
$30.50M |
|
$-22.56M |
|
$1.33M |
|
$-21.22M |
|
$-21.22M |
|
$-21.23M |
|
$-21.23M |
|
$-21.23M |
|
$-21.23M |
|
$-22.56M |
|
$-22.53M |
|
16.73M |
|
16.73M |
|
$-1.27 |
|
$-1.27 |
|
| Balance Sheet Financials | |
$49.94M |
|
$0.01M |
|
$0.01M |
|
$49.95M |
|
$5.87M |
|
-- |
|
$1.05M |
|
$6.92M |
|
$43.03M |
|
$43.03M |
|
$43.03M |
|
20.93M |
|
| Cash Flow Statement Financials | |
$-10.74M |
|
$-1.16M |
|
$20.39M |
|
$38.34M |
|
$46.82M |
|
$8.48M |
|
$4.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-283.87% |
|
-283.87% |
|
-283.52% |
|
-267.10% |
|
-267.14% |
|
$-11.90M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
-- |
|
-- |
|
-- |
|
-49.33% |
|
|
Return on Tangible Equity |
-49.33% |
-42.49% |
|
-49.33% |
|
$2.06 |
|
$-0.71 |
|
$-0.64 |
|